#News: InMed Pharmaceuticals Announces INM-901 Demonstrates Statistically Significant Reduction in Neuroinflammation in a Long-Term Preclinical Alzheimerβs Disease Study
Read full news release: https://t.co/6xKXEHo9Xo
$INM #Alzheimers#Neuroinflammation#Preclinical#study